Cannordic

CANNORDIC A/S is a Danish medical technology and pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative, substance-based medical devices and cosmetics containing bioactive cannabidiol (CBD). Operating as a subsidiary of CS MEDICA Group, the company focuses on providing evidence-based, over-the-counter (OTC) alternatives for pain management, autoimmune diseases, and stress-related disorders. Its flagship product line, marketed under the CANNASEN® brand, includes clinically tested topical treatments such as pain patches, arthritis gels, psoriasis gels, and protective nasal sprays. CANNORDIC leverages modern cannabinoid technology and strict compliance with EU Medical Device Regulations (MDR) to deliver safe, non-addictive therapeutic solutions to global markets.